European Treatment and Outcome Study score does not predict imatinib treatment response and outcome in chronic myeloid leukemia patientsEri Yamamoto, Yoshiaki Ishigatsubo, Etsuko Yamazaki et al.|Cancer Science|2013Cited by 39
Serum ferritin level is a prognostic marker in patients with peripheral T‐cell lymphomaSatoshi Koyama, Hideaki Nakajima, Shin Fujisawa et al.|International Journal of Laboratory Hematology|2016Cited by 35
Prognostic significance of serum beta-2 microglobulin level in Hodgkin lymphoma treated with ABVD-based therapyYuki Nakajima, Yoshiaki Ishigatsubo, Naoto Tomita et al.|Medical Oncology|2014Cited by 15
Analysis of outcomes in patients with supra-diaphragmatic vs infra-diaphragmatic diffuse large B cell lymphoma treated with R-CHOP therapyYuki Nakajima, Yoshiaki Ishigatsubo, Naoto Tomita et al.|Leukemia Research|2014Cited by 12
Serum Beta-2 Microglobulin Level As a Useful Prognostic Marker Of Hodgkin LymphomaYuki Nakajima, Yoshiaki Ishigatsubo, Naoto Tomita et al.|Blood|2013Cited by 4